SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:his-23479"
 

Search: onr:"swepub:oai:DiVA.org:his-23479" > Controlled Delivery...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Controlled Delivery of Human Cells by Temperature Responsive Microcapsules

Mak, Wing Cheung (author)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
Olesen, Kim (author)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
Sivlér, Petter (author)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
show more...
Lee, Chyan-Jang, 1976- (author)
Linköpings universitet,Institutionen för klinisk och experimentell medicin,Medicinska fakulteten,Integrative Regenerative Medicine Centre
Moreno-Jimenez, I. (author)
Integrative Regenerative Medicine Centre, Department of Clinical and Experimental Medicine, Linköping University, Sweden ; Bone & Joint Research Group, Stem Cells & Regeneration Institute of Developmental Sciences, Southampton General Hospital, Southampton, Hampshire SO16 6YD, UK
Edin, Joel (author)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
Courtman, D. (author)
Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario K1H 8L6, Canada
Skog, Mårten (author)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
Griffith, May (author)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
show less...
 (creator_code:org_t)
2015-06-18
2015
English.
In: Journal of Functional Biomaterials. - : MDPI. - 2079-4983. ; 6:2, s. 439-453
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Cell therapy is one of the most promising areas within regenerative medicine. However, its full potential is limited by the rapid loss of introduced therapeutic cells before their full effects can be exploited, due in part to anoikis, and in part to the adverse environments often found within the pathologic tissues that the cells have been grafted into. Encapsulation of individual cells has been proposed as a means of increasing cell viability. In this study, we developed a facile, high throughput method for creating temperature responsive microcapsules comprising agarose, gelatin and fibrinogen for delivery and subsequent controlled release of cells. We verified the hypothesis that composite capsules combining agarose and gelatin, which possess different phase transition temperatures from solid to liquid, facilitated the destabilization of the capsules for cell release. Cell encapsulation and controlled release was demonstrated using human fibroblasts as model cells, as well as a therapeutically relevant cell line—human umbilical vein endothelial cells (HUVECs). While such temperature responsive cell microcapsules promise effective, controlled release of potential therapeutic cells at physiological temperatures, further work will be needed to augment the composition of the microcapsules and optimize the numbers of cells per capsule prior to clinical evaluation.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Biomaterialvetenskap (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Biomaterials Science (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)

Keyword

cell encapsulation
microcapsules
hydrogel
cell delivery
temperature responsive
human fibroblast
human umbilical vein endothelial cells

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view